Polycystic Ovarian Syndrome
Polycystic Ovarian Syndrome - Related Videos
08:20
A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
0 Views •
Cited by 20 •
2018
We describe the development of a lean PCOS-like mouse model with dihydrotestosterone pellet to study the pathophysiology of PCOS and the offspring from these PCOS-like dams.
04:49
A Modified Technique for Inducing Polycystic Ovary Syndrome in Mice
0 Views •
Cited by 1 •
2024
This protocol introduces a technique for inducing polycystic ovary syndrome (PCOS) models in mice through controlled letrozole release using mini-pumps. Under adequate anesthesia, the mini-pump was implanted subcutaneously, and PCOS was successfully induced in the mice after a certain period of the mini-pump release.
09:44
Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
0 Views •
2022
This study describes the direct measurement of hepatic glucose production in a polycystic ovary syndrome mouse model by using a stable isotopic glucose tracer via tail vein in both fasting and glucose-rich states in tandem.
03:53
Subcutaneous Dihydrotestosterone (DHT) Treatment: Mouse Model of Polycystic Ovary Syndrome (PCOS)
0 Views •
2023
This article describes a way to prepare and insert dihydrotestosterone (DHT) pellets to model Polycystic Ovary Syndrome (PCOS) in mice. The example protocol demonstrates the procedure in mice used for reproductive and metabolic studies.
07:35
Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
0 Views •
Cited by 14 •
2015
The use of ultra-high field MRI as a non-invasive way to obtain phenotypic information of rodent models for polycystic kidney disease and to monitor interventions is described. Compared with the traditional histological approach, MRI images can be acquired in vivo, allowing for longitudinal follow-up.
FAQs
These organs and tissues form an interconnected regulatory system rather than isolated contributors. Altered communication can affect ovarian androgen production, follicle development, ovulation, and metabolic function at the same time. This systems-level view helps explain why reproductive findings and metabolic features may appear together, and why studying PCOS requires attention to both hormone regulation and tissue metabolism.
Increased androgen activity can disrupt the normal progression of ovarian follicles, the structures associated with egg development. When follicle development is disturbed, ovulation may become irregular or fail to occur consistently, contributing to disrupted menstrual cycles and possible infertility. The same androgen-related changes may also be associated with acne and excess hair growth, linking reproductive and visible clinical features.
No. The overview identifies polycystic ovarian morphology as a feature present in some individuals, not as a universal finding. This distinction is biologically important because ovarian appearance represents only one aspect of the condition. Investigators also consider ovulation, androgen activity, hormone communication, and metabolic tissues when examining how PCOS affects an individual.
Metabolic tissues participate in the hormone-related communication linked with ovarian function. When this communication is altered, insulin resistance may develop and coexist with changes in androgen production and ovulation. This connection places PCOS at the intersection of reproductive and metabolic biology, helping researchers investigate why a disorder affecting ovarian function can also involve broader metabolic complications.
A biological investigation can examine hormone regulation, ovarian function, follicle development, ovulation, and communication between reproductive organs and metabolic tissues. Considering these processes together helps researchers connect molecular or physiological changes with outcomes such as irregular cycles, infertility, androgen-related symptoms, and insulin resistance. This integrated approach also supports the search for more individualized diagnostic and management strategies.
PCOS can involve different combinations of disrupted ovulation, elevated androgen activity, ovarian morphology, reproductive symptoms, and metabolic complications. Because these features do not necessarily occur in the same pattern for every individual, management benefits from recognizing the person’s specific biological and clinical profile. Studying these variations can support improved diagnosis and more individualized approaches to care.
PCOS provides a model for studying how hormone regulation influences ovarian function and fertility. Researchers can examine why altered communication affects follicle development, menstrual cycling, and ovulation, while also considering the contribution of metabolic tissues. These questions connect reproductive biology with metabolic health and may clarify how endocrine changes produce both reproductive outcomes and wider physiological effects.